Controlled ovarian hyperstimulation: are we monitoring the appropriate sex-steroid hormones?

被引：12

作者：

Orvieto, Raoul ^{[1
,2
]}

Hod, Eduard

Volodarsky, Michael

Homburg, Roy

Rabinson, Jacob

Meltcer, Simion

机构：

[1] Barzilai Govt Hosp, Dept Obstet & Gynecol, Infertil & IVF Unit, IL-78278 Ashqelon, Israel

[2] Ben Gurion Univ Negev, Sch Med, IL-84105 Beer Sheva, Israel

来源：

FERTILITY AND STERILITY | 2008年 / 89卷 / 05期

关键词：

D O I：

10.1016/j.fertnstert.2007.05.024

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

We prospectively evaluated the behavior of serum 17-hydroxyprogesterone (17-OHP), sex-steroid hormones, and C-reactive protein (CRP) levels in 27 patients during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF). While routine measurement of COH via serum 17-OHP may replace estradiol (E-2) and progesterone levels, additional studies are needed to elucidate the ceiling level of serum 17-OHP beyond which intervention is required to prevent severe ovarian hyperstimulation syndrome.

引用

收藏

页码：1269 / 1272

页数：4

相关论文

共 14 条

[1]

Can we abandon routine evaluation of serum estradiol levels during controlled ovarian hyperstimulation for assisted reproduction? [J].

Ben-Shlomo, I ;

Geslevich, J ;

Shalev, E .

FERTILITY AND STERILITY, 2001, 76 (02) :300-303

[2]

SONOGRAPHIC MONITORING OF OVARIAN FOLLICULAR DEVELOPMENT [J].

FLEISCHER, AC ;

DANIELL, JF ;

RODIER, J ;

LINDSAY, AM ;

JAMES, AE .

JOURNAL OF CLINICAL ULTRASOUND, 1981, 9 (06) :275-280

[3]

ULTRASONIC AND ENDOCRINOLOGIC RELATIONSHIPS IN SPONTANEOUS AND INDUCED FOLLICULAR PHASE [J].

MANGO, D ;

SCIRPA, P ;

SPINA, MA ;

BATTAGLIA, F ;

TARTAGLIA, E ;

MANNA, P ;

RICCI, S ;

IACONA, T .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (01) :7-13

[4]

Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles [J].

Orvieto, R ;

Yulzari-Roll, V ;

La Marca, A ;

Ashkenazi, J ;

Fisch, B .

GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (04) :218-222

[5]

Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation [J].

Orvieto, R ;

Fisch, N ;

Yulzari-Roll, V ;

La Marca, A .

GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (03) :170-173

[6]

Controlled ovarian hyperstimulation - An inflammatory state [J].

Orvieto, R .

JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (07) :424-426

[7]

C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle [J].

Orvieto, R ;

Chen, R ;

Ashkenazi, J ;

Ben-Harush, A ;

Bar, J ;

Fisch, B .

HUMAN REPRODUCTION, 2004, 19 (02) :357-359

[8]

Prediction of ovarian hyperstimulation syndrome - Challenging the estradiol mythos [J].

Orvieto, R .

HUMAN REPRODUCTION, 2003, 18 (04) :665-667

[9]

The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization [J].

Orvieto, Raoul ;

Zohav, Efraim ;

Scharf, Shimon ;

Rabinson, Jacob ;

Meltcer, Simion ;

Anteby, Eyal Y. ;

Homburg, Roy .

GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (02) :72-75

[10]

Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation [J].

Orvieto, Raoul ;

Zagatsky, Irina ;

Yulzari-Roll, Vered ;

La Marca, Antonio ;

Fisch, Benjamin .

GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (08) :437-440